IDEXX Laboratories, Inc.
IDXX
株式のランク
#555
IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing,... IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing, and distributing a wide array of products and services. Its primary client base includes companion animal veterinary practices, the livestock and poultry industries, dairy operations, and water quality testing sectors. The company organizes its operations across several key divisions: the Companion Animal Group (CAG), Water Quality Products, Livestock, Poultry, and Dairy (LPD), and additional segments. For companion animals, IDEXX offers a comprehensive suite of point-of-care veterinary diagnostic tools, such as instruments, consumables, and rapid assay kits. It also provides reference laboratory diagnostic and consultation services, alongside practice management and diagnostic imaging solutions for veterinarians. Furthermore, the company supports the biomedical research community with health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services. In the livestock, poultry, and dairy markets, IDEXX supplies diagnostic and health-monitoring solutions. Its water testing portfolio includes products designed to detect various microbiological contaminants, notably the Colilert, Colilert-18, and Colisure tests for total coliforms and E. coli, as well as Enterolert, Pseudalert, Filta-Max, Filta-Max xpress, Legiolert, and Quanti-Tray products. Beyond these, IDEXX extends its reach to human point-of-care medical diagnostics, offering electrolyte and blood gas analyzers, and SARS-CoV-2 RT-PCR tests. Other key offerings encompass in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers, as well as SNAP rapid assay test kits. Veterinary software and services for both independent clinics and large corporate veterinary groups are also part of its offerings. The company distributes its extensive product and service catalog through its own dedicated marketing, customer service, sales, and technical service teams, supplemented by independent distributors and other resellers. IDEXX Laboratories, Inc. was established in 1983 and maintains its headquarters in Westbrook, Maine.
株価
$555.06
時価総額
$43.73B
変化（1日）
-0.51%
変化（1年）
-12.88%
国
US
取引 IDEXX Laboratories, Inc. (IDXX)
カテゴリー
Healthcare
IDEXX Laboratories, Inc.（IDXX）の収益
Jun 2026 時点の収益 TTM: $4.55B
IDEXX Laboratories, Inc. の最新の財務報告によると、現在の収益 (TTM) は $4.55B です。2024 年には $3.90B の収益があり、これは 2023 年の $3.66B と比較して 増加 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
IDEXX Laboratories, Inc. の収益履歴（2000 ～ 2026）
各年末の収益
| 年 | 収益 | 変化 |
|---|---|---|
| 2026 (TTM) | $4.55B | 5.80% |
| 2025 | $4.30B | 10.42% |
| 2024 | $3.90B | 6.46% |
| 2023 | $3.66B | 8.72% |
| 2022 | $3.37B | 4.73% |
| 2021 | $3.22B | 18.79% |
| 2020 | $2.71B | 12.45% |
| 2019 | $2.41B | 8.75% |
| 2018 | $2.21B | 12.40% |
| 2017 | $1.97B | 10.91% |
| 2016 | $1.78B | 10.83% |
| 2015 | $1.60B | 7.81% |
| 2014 | $1.49B | 7.90% |
| 2013 | $1.38B | 6.47% |
| 2012 | $1.29B | 6.13% |
| 2011 | $1.22B | 10.45% |
| 2010 | $1.10B | 6.96% |
| 2009 | $1.03B | 0.74% |
| 2008 | $1.02B | 11.00% |
| 2007 | $922.56M | 24.82% |
| 2006 | $739.12M | 15.83% |
| 2005 | $638.10M | 16.19% |
| 2004 | $549.18M | 15.38% |
| 2003 | $475.99M | 15.34% |
| 2002 | $412.67M | 6.89% |
| 2001 | $386.08M | 5.08% |
| 2000 | $367.43M | 0.00% |
同業他社の収益
| 企業 | 収益 | 収益の差 | 国 |
|---|---|---|---|
| $46.34B | 917.65% |
US
|
|
| $25.11B | 451.41% |
US
|
|
| $2.71B | -40.55% |
US
|
|
| - | - |
CN
|
|
| $7.37B | 61.91% |
US
|
